Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.

MLA

Lidumniece, Elina, et al. “Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.” Journal of Medicinal Chemistry, vol. 65, no. 19, Oct. 2022, pp. 12535–45. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.2c01093.

APA

Lidumniece, E., Withers-Martinez, C., Hackett, F., Blackman, M. J., & Jirgensons, A. (2022). Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery. Journal of Medicinal Chemistry, 65(19), 12535–12545. https://doi.org/10.1021/acs.jmedchem.2c01093

Chicago

Lidumniece, Elina, Chrislaine Withers-Martinez, Fiona Hackett, Michael J Blackman, and Aigars Jirgensons. 2022. “Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.” Journal of Medicinal Chemistry 65 (19): 12535–45. doi:10.1021/acs.jmedchem.2c01093.